Department of Medicine: Division of Liver Diseases

Gold Divider 4Col

Overview

Three pressing concerns drive research on liver diseases at Mount Sinai: the increase in chronic liver disease, the growing incidence of liver cancer and the shortage of organs for liver transplants. Basic, translational and clinical research in the Division of Liver Disease is geared toward finding solutions.

The division is particularly renowned for its leadership in the study of hepatic fibrosis, hepatocellular carcinoma, hepatitis C virus infection, primary biliary cirrhosis, and liver immunology.

Team

  • Meena Bansal
  • Andrea Branch (Priniciple Investigator)
  • Charissa Chang (Priniciple Investigator)
  • Douglas Dieterich (Priniciple Investigator)
  • Scott Friedman (Priniciple Investigator)
  • Priya Grewal
  • Hussien Elsiesy
  • Eric Lemmer
  • Lawrence Liu
  • Josep Llovet
  • Patricia Lopez
  • Paul Martin
  • Natalia Nieto (Priniciple Investigator)
  • Joseph Odin
  • Kirsten Sadler-Edepli
  • Thomas Schiano

Grants

Training Program in Investigative Gastroenterology
Priniciple Investigator: Scott Friedman
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 01-May-01 - 30-Jun-11

Apoptotic Cholangiocytes in Primary Biliary Cirrhosis
Principle Investigator: Joseph A. Odin
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 01-Jul-01 - 30-Jun-07

IL-6 Regulation of Matrix Degradation in Liver Fibrosis
Principle Investigator: Meena B. Bansal
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 15-Feb-02 - 31-Jan-07

Mount Sinai: Anti-Fibrosis Drug Discovery Center
Priniciple Investigator: Scott Friedman
Funding Agency: PRIVATE DONOR
Project Period: 01-Aug-01 - 31-Jul-07

Mount Sinai: Anti-Fibrosis Drug Discovery Center
Priniciple Investigator: Scott Friedman
Funding Agency: PRIVATE DONOR
Project Period: 01-Aug-01 - 31-Jul-07

HCV Alterante Reading Frame Protein in HIV-HCV Co-Infection
Priniciple Investigator: Andrea Branch
FUNDING AGENCY: NATIONAL INSTITUTE ON DRUG ABUSE
Project Period: 30-Sep-03 - 30-Jun-08

Peginterferon 2a for Chronic Hepatitis
Priniciple Investigator: Douglas Dieterich
FUNDING AGENCY: HEPATITIS RESOURCE NETWORK
Project Period: 01-Jul-02 - 30-Jun-07

Modulation of HCV Gene Expression
Priniciple Investigator: Andrea Branch
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 01-Apr-04 - 28-Feb-09

Intercellular Communication/Kupfer & Stellate Cells
Priniciple Investigator:Natalia Nieto
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 15-Sep-05 - 30-Jun-10

Sucralfate to Prevent Esophageal Ulcers/Variceal Ligatio
Principle Investigator: Charissa Chang
AASLD/SCHERING ADVANCED HEPATOLOGY
Project Period: 01-Jul-05 - 30-Jun-06

Analysis of Altered Phagocytosis in Liver Disease
Principle Investigator: Joseph A. Odin
Funding Agency: IRMA T. HIRSCHL
Project Period: 01-Jan-05 - 31-Dec-10

Neurohumoral Factors Renal Dysfunction Liver Transplant
Principle Investigator: Costica Aloman
Funding Agency: AASLD/SCHERING ADVANCED HEPATOLOGY
Project Period: 01-Jul-06 - 30-Jun-07

Vitamin D Supplementation Immune Function in PBC
Principle Investigator: Joseph A. Odin
FUNDING AGENCY: AMERICAN LIVER FOUNDATION
Project Period: 01-Jul-06 - 30-Jun-08

Role of Stellate Cells in Hepatic Fibrosis
Priniciple Investigator: Scott Friedman
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 01-Jan-87 - 30-Jun-08

The Role of KLF6 in Hepatic Fibrosis
Priniciple Investigator: Scott Friedman
FUNDING AGENCY: NATIONAL INSTITUTE OF DIABETES, DIGESTIVE AND KIDNEY DISEASES
Project Period: 01-May-00 - 30-Apr-10

Primary Biliary Cirrhosis: Pathobiology, Course and Tx
Priniciple Investigator: Scott Friedman
FUNDING AGENCY: ARTZT FAMILY FOUNDATION TRUST
Project Period: 01-Jan-99 - 31-Dec-06